Endstage Renal Disease Clinical Trial
Official title:
Improving Adherence in Renal Dialysis Patients; a Randomized Crossover Trial for an Electronic Intervention
Verified date | May 2018 |
Source | Washington University School of Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Dialysis treatment non-adherence is a prevalent problem among the end-stage renal population
receiving chronic hemodialysis. The complications associated with missed or shortened
dialysis sessions are serious and frequently require emergent medical care or
hospitalization. Previous studies have shown that electronic messages have significantly
improved attendance rates in a primary care setting, but these messages have not been
validated in the chronic dialysis population.
An electronic intervention has been developed by Epharmix, a WUSTL IDEA Labs
(ideas.wustl.edu) team, which has the capacity to use automated SMS text messages and/or
phone calls to notify patients prior to each upcoming appointment, as well as alert a
designated patient advocate. Patients receiving the messages are provided with key contact
information for a dialysis rescheduling phone line, transportation resources, social work
services, etc. They may also receive instructions on what to do if they are experiencing
physical symptoms and need educational facts about dialysis. In particular, the intervention
is designed to demonstrate to patients that the center cares and is concerned for their
health and wellbeing. This intervention may potentially improve patient adherence to their
scheduled sessions, increase patient satisfaction with their treatment, and prevent medical
complications associated with missed dialysis appointments.
This study aims to determine whether an electronic intervention, which sends SMS text
messages or phone calls of key dialysis treatment information, is able to improve dialysis
treatment session attendance among dialysis patients with a history of poor attendance. We
secondarily aim to identify the factors that may be barriers to dialysis treatment session
attendance and the emergency department or hospital utilization associated with missed
dialysis treatments.
Patients will be prospectively identified, recruited, and randomized into two groups. Group A
will receive the electronic intervention prior to their appointments; Group B will not
receive any electronic intervention. After 8 weeks, crossover will occur for both groups and
the study will continue for an additional 8 weeks. Participants' clinic records will be
reviewed to determine the numbers of missed and attended appointments, as well as records of
ED visits and hospital admissions. Subjects will be asked to complete a post-study
satisfaction questionnaire.
Status | Completed |
Enrollment | 26 |
Est. completion date | December 1, 2016 |
Est. primary completion date | June 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - All potential subjects are between 18 and 75 years of age, and have been receiving hemodialysis treatments, scheduled for 3 sessions/week, for at least 8 weeks at the Chromalloy American Kidney Center or Washington University Dialysis Center. - The individuals will be prospectively identified as whether they have a history of occasional non-attendance to dialysis treatments, defined as 2-3 missed appointments in the preceding 8 week period or 24 scheduled sessions. These subjects will be enrolled as part of one cohort. Individuals who have frequent non-attendance, defined as 4-6 missed appointments in the preceding 8 week period or 24 scheduled sessions, will be enrolled as a second cohort. - Subjects must be able to provide a phone number at which they can either receive SMS text messages and/or phone calls. The cost of messages will be paid for by the sender. Subjects must be able and willing to provide consent and authorize access of their medical record and dialysis clinic record for study use. Exclusion Criteria: - Persons not receiving ongoing hemodialysis treatments or new patients with less than 8 weeks of treatments at the dialysis center. - Persons not intended to receive 3 dialysis treatments/week for the next 8 weeks. - Pregnant individuals. - Persons unable to be contacted by phone call or SMS text message, or unwilling to provide their contact number. - Persons unwilling to consent and follow the assigned regimen and complete the required follow up. - Persons with severe neurological or cognitive disorders, limiting their ability to provide consent. |
Country | Name | City | State |
---|---|---|---|
United States | Washington University School of Medicine - Barnes Jewish Hospital | Saint Louis | Missouri |
Lead Sponsor | Collaborator |
---|---|
Washington University School of Medicine |
United States,
Bame SI, Petersen N, Wray NP. Variation in hemodialysis patient compliance according to demographic characteristics. Soc Sci Med. 1993 Oct;37(8):1035-43. — View Citation
Cummings KM, Becker MH, Kirscht JP, Levin NW. Intervention strategies to improve compliance with medical regimens by ambulatory hemodialysis patients. J Behav Med. 1981 Mar;4(1):111-27. — View Citation
Junod Perron N, Dao MD, Righini NC, Humair JP, Broers B, Narring F, Haller DM, Gaspoz JM. Text-messaging versus telephone reminders to reduce missed appointments in an academic primary care clinic: a randomized controlled trial. BMC Health Serv Res. 2013 Apr 4;13:125. doi: 10.1186/1472-6963-13-125. — View Citation
Lamping, D. L. & Campbell, K. A. Hemodialysis Compliance: Assessment, Prediction, and Intervention: Part I. Seminars in dialysis 3, 52-56 (1990).
Lamping, D. L. & Campbell, K. A. Hemodialysis Compliance: Assessment, Prediction, and Intervention: Part II. Seminars in dialysis 3, (1990).
Parikh A, Gupta K, Wilson AC, Fields K, Cosgrove NM, Kostis JB. The effectiveness of outpatient appointment reminder systems in reducing no-show rates. Am J Med. 2010 Jun;123(6):542-8. doi: 10.1016/j.amjmed.2009.11.022. — View Citation
Sherman RA, Cody RP, Matera JJ, Rogers ME, Solanchick JC. Deficiencies in delivered hemodialysis therapy due to missed and shortened treatments. Am J Kidney Dis. 1994 Dec;24(6):921-3. — View Citation
U.S. Renal Data System Annual Data Report. Chapter 1: Incidence, prevalence, patient characteristics and modality. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD https://www.usrds.org/2015/view/v2_01.aspx (2015)
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Dialysis appointment attendance | The primary objective of this prospective randomized control study is to assess the effects of an electronic intervention, which sends automated SMS text messages or pre-recorded phone messages, on attendance rate to dialysis sessions among non-adherent dialysis patients. | 16 weeks | |
Secondary | Hospitalization | Compare the number of emergency department visits and hospitalizations between groups during intervention and control phases | 16 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03023748 -
Intravenous Paricalcitol in Chronic Hemodialysis Patients
|
Phase 4 | |
Terminated |
NCT00776191 -
Randomized Multicenter Cross-over Study to Compare the Effect of Physioneal 35 to 40 on the Protein Metabolism
|
Phase 4 | |
Completed |
NCT00745914 -
Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease Patients
|
N/A | |
Completed |
NCT02981706 -
Comparison of AVF Versus AVG in Elderly Patients Starting Dialysis
|
N/A | |
Completed |
NCT02946229 -
Data Collection for Next Generation Ultrasound Technology Development
|
N/A | |
Completed |
NCT02966028 -
Effect of SNF472 on Progression of Cardiovascular Calcification in End-Stage-Renal-Disease (ESRD) Patients on Hemodialysis (HD)
|
Phase 2 | |
Completed |
NCT02976246 -
Effect of Vitamin K2 (MK7) on Cardiovascular and Bone Disease in Dialysis Patients
|
Phase 4 | |
Recruiting |
NCT02957877 -
LMWH Infusion as Anticoagulation for Home HD
|
Phase 4 | |
Completed |
NCT00745719 -
Parathyroidectomy in Endstage Renal Disease
|
N/A | |
Completed |
NCT03010072 -
The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum
|
Phase 2 | |
Recruiting |
NCT03020303 -
Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease
|
Phase 3 | |
Completed |
NCT00745589 -
Sevelamer Hydrochloride in Peritoneal Dialysis Patients
|
N/A | |
Not yet recruiting |
NCT02976688 -
Effects of Short-chain Fatty Acids on Inflammatory and Metabolic Parameters in Maintenance Hemodialysis
|
Phase 2/Phase 3 | |
Withdrawn |
NCT00502268 -
Vitamin D and Carboxy PTH Fragments in Coronary Calcification
|
Phase 4 | |
Completed |
NCT02977117 -
The Effect of Increasing Dialysate Magnesium on Calcification Propensity in Subjects on Haemodialysis
|
Phase 2 | |
Completed |
NCT02207153 -
Risk Assessment by Cardiovascular Biomarkers in Chronic Dialysis Patients
|
||
Completed |
NCT02866214 -
Effect of Febuxostat on Endothelial Dysfunction in Hemodialysis Patients.
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT03054454 -
A Podiatry Led MDT Intervention to Reduce the Burden of Foot Disease in Patients With End Stage Kidney Failure
|
N/A |